Artica Therapeutics develops novel therapies for patients suffering from severe autoimmune and inflammatory disorders using covalent chemistry to create drugs that inactivate disease-causing proteins over an extended period of time.
investor of
Metrics
marketPRIVATE
msh_idCOM:ARTICA-TX
localech
websitehttps://www.artica-tx.com
source_ref82f50918-373f-48f8-ac8b-98bc348ae19d
products_or_servicesDevelopment of covalent drugs for autoimmune and inflammatory disorders